Patents Assigned to The University
  • Patent number: 11760823
    Abstract: The invention relates in general to hydrophilic, biocompatible dendronised polymers, to complexes comprising the dendronised polymers, to methods of preparing the dendronised polymer and to uses of the dendronised polymer as a non-viral transfection agent for the delivery of biomolecules, in particular, genome editing tools, into a cell.
    Type: Grant
    Filed: September 12, 2018
    Date of Patent: September 19, 2023
    Assignee: The University of Western Australia
    Inventors: Killugudi Swaminatha Iyer, Marck Norret, Jessica Kretzmann, Diwei Ho
  • Patent number: 11759437
    Abstract: The present invention describes a method of preventing, ameliorating and/or treating disorders or diseases associated with the integrated stress response (ISR) involving the p-eIF2? pathway arising from various cellular stresses such as oxidative stress, hypoxia and ER stress, chronic or prolonged bio-mechanical stress. In one embodiment, the present invention provides a method which prevents or alleviates aberrant cell differentiation that is caused by the activation of the integrated stress response and thereby prevents or alleviates conditions, disorders or diseases resulting therefrom. In one embodiment, ISR-associated diseases subject to the present invention include but are not limited to skeletal disorders including disc degeneration, MCDS and other skeletal dysplasias, cancers, inflammatory diseases, diabetes, fibrosis, obesity and neurodegenerative diseases.
    Type: Grant
    Filed: September 22, 2017
    Date of Patent: September 19, 2023
    Assignee: The University of Hong Kong
    Inventors: Song Eng Kathryn Cheah, Danny Chan, Cheng Wang, Cheuk Wing Wilson Chan
  • Patent number: 11763451
    Abstract: The disclosure describes imaging and therapy techniques comprising nanodroplets. More particularly, aspects of the disclosure relate to the use of nanodroplets to modify nanobubbles or microbubbles to provide improved imaging and/or therapeutic techniques and compositions.
    Type: Grant
    Filed: May 13, 2022
    Date of Patent: September 19, 2023
    Assignee: The Board of Regents of The University of Texas System
    Inventors: Robert F. Mattrey, Caroline De Gracia Lux, Jacques Lux, Zhenghong Gao, Carlos J. Brambila
  • Patent number: 11761105
    Abstract: Apparatuses and methods for producing hydrogen peroxide by performing coupled chemical and electrochemical reactions are disclosed. An electrochemical cell has a chemical reaction chamber configured to hydrogenate a shuttle molecule and an electrochemical chamber configured to electrochemically dissociate water to form hydrogen ions at an anode, and to reduce the hydrogen ions to atomic hydrogen at a cathode. The chemical reaction chamber and the anode chamber are separated by a metallic membrane. The metallic membrane acts as a cathode of the cell, a hydrogen-selective layer and a catalyst. The metallic membrane may comprise a layer of palladium or a palladium alloy. A layer of co-catalyst may optionally be electrodeposited on the layer of palladium or palladium alloy. An ion exchange membrane separates the metallic membrane and the anode chamber. The hydrogenated shuttle molecule may be supplied to a reactor for contacting an oxygen-containing gas to yield hydrogen peroxide.
    Type: Grant
    Filed: February 3, 2023
    Date of Patent: September 19, 2023
    Assignee: The University of British Columbia
    Inventors: Aoxue Huang, Roxanna Delima, Ryan Jansonius, Curtis Berlinguette
  • Publication number: 20230285446
    Abstract: The disclosure provides products and methods of treating diseases and disorders involving microbial pathogens, such as intestinal microbial pathogens, e.g., Pseudomonas aeruginosa, by administering an effective amount of a phosphorylated polyethylene glycol compound of defined structural organization. Those diseases and disorders characterized by an epithelium attacked by a microbial pathogen are contemplated, including gastrointestinal infections and inflammation, e.g., treatment of intestinal or esophageal anastomosis or treatment or suppression of anastomotic leakage.
    Type: Application
    Filed: January 18, 2023
    Publication date: September 14, 2023
    Applicants: The University of Chicago, UChicago Argonne, LLC
    Inventors: John C. Alverdy, Matthew Tirrell, Olga Y. Zaborina, Jun Mao, Wei Chen
  • Publication number: 20230285558
    Abstract: Embodiments of the disclosure encompass methods and compositions related to cell therapy treatment, including for cancer. In specific embodiments, the disclosure concerns adoptive cell therapy cancer treatment in which tumor-1 infiltrating lymphocytes and/or engineered T cells are modified to increase their efficacy as a cancer treatment. In specific cases, the cells are engineered for knock out of one or more genes, such as Signaling Threshold Regulating Transmembrane Adaptor 1 (SIT1), Bone Marrow Stromal Cell Antigen 2 (BST2), and/or programmed cell death protein 1 (PD-1).
    Type: Application
    Filed: July 23, 2021
    Publication date: September 14, 2023
    Applicant: Board of Regents, The University of Texas System
    Inventors: Patrick HWU, Barbara M. NASSIF RAUSSEO
  • Publication number: 20230285405
    Abstract: In aspects, the invention provides a method of treating or preventing a nidovirus or picornavirus infection in a subject, the method comprising administering to a subject in need thereof an effective amount of an active agent of butamben, butylparaben, conivaptan, amphotericin B, pentoxyverine, lapatinib, vilazodone, imatinib (STI571), benztropine, raloxifene, solifenacin, retapamulin, bafetinib (INNO-406), imipramine, trimipramine, tolterodine, clomipramine, velpatasvir, cediranib (AZD2171), azelastine, desloratadine, nortriptyline, propafenone, mebeverine, elbasvir, cepharanthine, flupenthixol dihydrochloride, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: August 6, 2021
    Publication date: September 14, 2023
    Applicant: The University of Chicago
    Inventors: Savas Tay, Glenn Randall, Nir Drayman, Siquan Chen
  • Publication number: 20230285507
    Abstract: The invention features compositions featuring (a) one or more of connective tissue growth factor (CTGF) and human C-terminal CTGF peptide; and (b) one or more of insulin and IGF-1; and methods of using such compositions to reduce cardiac tissue damage associated with an ischemic event or to enhance engraftment of a cell in a cardiac tissue.
    Type: Application
    Filed: January 25, 2023
    Publication date: September 14, 2023
    Applicant: The University of Vermont and State Agriculture College
    Inventor: Jeffrey SPEES
  • Publication number: 20230288415
    Abstract: The present disclosure is directed to methods and compositions for the prediction and treatment of immunotherapy-induced toxicities, as well as improved methods for the treatment of cancer with immunotherapies.
    Type: Application
    Filed: December 7, 2022
    Publication date: September 14, 2023
    Applicant: The Board of Regents of The University of Texas System
    Inventors: Edward K. Wakeland, David E. Gerber, Quanzhen Li, Shaheen Khan, Saad Khan, Yang Xie, Jason Y. Park, Farjana Fattah, Xin Luo
  • Patent number: 11754778
    Abstract: A photoreactor including a reservoir configured to hold water, the reservoir defining an inlet and an outlet, and a multiplicity of optical fiber assemblies positioned in the reservoir. Each optical fiber assembly includes one or more optical fibers coated with a composition comprising a photoresponsive polymer and a light source optically coupled to the one or more optical fibers. The photoresponsive polymer undergoes a change from an initial state to an irradiated state when irradiated with light from the light source, and photoresponsive polymer in the irradiated state is adapted to bind an ion from the water.
    Type: Grant
    Filed: November 21, 2019
    Date of Patent: September 12, 2023
    Assignees: Arizona Board of Regents on behalf of Arizona State University, Board of Regents; The University of Texas System
    Inventors: Paul K. Westerhoff, Shahnawaz Sinha, Juan Noveron
  • Patent number: 11751841
    Abstract: A method for evaluating mechanical anisotropy of a material sample to determine a characteristic of the sample includes interrogating a material sample a plurality of times. Each interrogation includes: applying a force having a direction, having a coronal plane normal to the direction of the force, and having an oval or other profile with long and short axes within the coronal plane, the long axis being oriented at a specified angle from a reference direction within the coronal plane; and measuring displacement of the material sample resulting from application of the force. The interrogations are taken at different angles of orientation within the coronal plane and different portions of the material sample are interrogated. For each measurement one or more parameters are calculated for the respective angle of orientation. A degree of anisotropy of the one or more parameters is determined and used to evaluate a characteristic of the material sample.
    Type: Grant
    Filed: February 16, 2021
    Date of Patent: September 12, 2023
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: Caterina Gallippi, Gabriela Torres
  • Patent number: 11751971
    Abstract: An imaging and display system for guiding medical interventions includes a wearable display, such as a goggle display, for viewing by a user. The display presents a composite, or combined image that includes pre-operative surgical navigation images, intraoperative images, and in-vivo microscopy images or sensing data. The pre-operative images are acquired from scanners, such as MRI and CT scanners, while the intra-operative images are acquired in real-time from a camera system carried by the goggle display for imaging the patient being treated so as to acquire intraoperative images, such as fluorescence images. A probe, such as a microscopy probe or a sensing probe, is used to acquire in-vivo imaging/sensing data from the patient. Additionally, the intra-operative and in-vivo images are acquired using tracking and registration techniques to align them with the pre-operative image and the patient to form a composite image for display by the goggle display.
    Type: Grant
    Filed: November 30, 2020
    Date of Patent: September 12, 2023
    Assignee: The University of Akron
    Inventor: Yang Liu
  • Patent number: 11753381
    Abstract: Disclosed herein are compounds which inhibit RIPK1, pharmaceutical compositions, and methods of treatment of RIPK1-mediated diseases, such as neurodegenerative disorders, inflammatory disorders, and cancer.
    Type: Grant
    Filed: September 25, 2020
    Date of Patent: September 12, 2023
    Assignee: Board of Regents, The University of Texas System
    Inventors: Richard T. Lewis, Matthew Michael Hamilton, William J. Ray, Fernando Alvarez, Dana E. Pfaffinger, Naphtali Reyna, Jason Cross, Suyambu Kesava Vijayan Ramaswamy
  • Patent number: 11751843
    Abstract: An ultrasound transducer probe holder device comprising a support piece; a base connected to the support piece; a cylindrical orifice within the support piece; a housing extending from the orifice and defining a cavity; a sleeve for insertion within the orifice; and an adjustment screw fitted in the housing for contact with the sleeve. The device supports and maintains the position of an ultrasound transducer probe to provide for a hands-free application of the device during different modalities of exercise required to instigate hyperemic conditions while providing x, y, z, positional adjustments of the probe relative to the patient.
    Type: Grant
    Filed: October 3, 2019
    Date of Patent: September 12, 2023
    Assignee: Board of Regents, The University of Texas System
    Inventors: Francisco Morales Acuna, Luis A. Ochoa, Alvaro N. Gurovich
  • Patent number: 11756650
    Abstract: Methods predict candidate epitopes in a protein by: providing a conformational sampling engine; obtaining a model of a protein suitable for use with the conformational sampling engine and comprising a native structure; applying a collective coordinate bias to the protein model, the collective coordinate bias causing the conformational sampling engine to in turn force the protein model to at least partially unfold from its native structure to an updated structure, wherein the collective coordinate bias is applied globally to at least a substantial portion of the protein model and is impartial as to where, within the substantial portion of the protein model, unfolding occurs; and analyzing the updated structure to identify one or more candidate epitopes, where the one or more candidate epitopes exhibit indicia of localized unfolding.
    Type: Grant
    Filed: November 9, 2016
    Date of Patent: September 12, 2023
    Assignee: The University of British Columbia
    Inventor: Steven Samuel Plotkin
  • Publication number: 20230280349
    Abstract: In aspects, the disclosure provides a method of differentiating a malignant tumor from a non-malignant tumor in a mammal having a tumor comprising determining in a sample from the mammal the level of one or more of: (1) transthyretin (TTR) RNA or protein, (2) dual oxidase 2 (DUOX2) RNA or protein, and (3) G-protein coupled receptor 179 (GPR179) RNA or protein.
    Type: Application
    Filed: March 1, 2023
    Publication date: September 7, 2023
    Applicants: The University of Chicago, Inova Health System, The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
    Inventors: Ayman Al-Hendy, Hiba Alkelani, Thomas Patrick Conrads, George Larry Maxwell, Nicholas William Bateman, Waleed Barakat
  • Patent number: 11744819
    Abstract: Pharmaceutical formulations are provided that include at least two antibiotically active ingredients: a cannabinoid that is one or more of cannabichromene (CBC), cannabidiol (CBD) and/or cannabigerol (CBG); a sesquiterpene that is one or both of a-humulene and/or ?-caryophyllene; and a lipopeptide antibiotic that is daptomycin or an analogue thereof. The antibiotically active ingredients may be provided in relative amounts that amplify their individual activities, including amounts that are synergistically effective in an assay to inhibit growth and/or reproduction of an Enterococcus faecium or an Enterococcus faecalis. Therapies are provided that utilize these formulations as anti-microbials, and provide for the combined use of two or more of the antibiotically active compounds.
    Type: Grant
    Filed: January 31, 2022
    Date of Patent: September 5, 2023
    Assignee: The University of British Columbia
    Inventors: Charles J. Thompson, Mark C. Pryjma, Dana M. Lambert, Manisha Dosanjh
  • Patent number: 11744926
    Abstract: A non-synthetic, hydrophilic, biodegradable, biocompatible polysaccharide based non-toxic anti-adhesion hydrogel barrier is disclosed herein. The barrier of the present invention is formed by constructing a unique interpenetrating, crosslinked network with a unique porosity. Furthermore, the barrier of the present invention is comprised of tunable biopolymers for controllable mechanical robustness and degradation. The barrier of the present invention effectively reduces unwanted adhesions using non-synthetic components.
    Type: Grant
    Filed: July 7, 2021
    Date of Patent: September 5, 2023
    Assignee: Board Of Regents, The University Of Texas System
    Inventors: Sarah Mayes, Christine E. Schmidt
  • Patent number: 11746355
    Abstract: The present invention relates to pathogen-resistant plants. In one aspect, plants comprising a heterologous expression cassette are provided, wherein the expression cassette comprises a polynucleotide that inhibits expression of a fungal pathogen gene and wherein the plant has increased resistance to a fungal pathogen or multiple pathogens compared to a control plant lacking the expression cassette. In another aspect, contacting a plant or a plant part with double stranded RNAs or small RNAs that inhibit expression of a fungal target gene or genes from multiple pathogens, wherein the plant has increased resistance to a pathogen or multiple pathogens compared to control plants that has not been contacted with the RNAs. Methods of making and cultivating pathogen-resistant plants are also provided.
    Type: Grant
    Filed: October 4, 2018
    Date of Patent: September 5, 2023
    Assignee: The Regents of The University of California
    Inventor: Hailing Jin
  • Patent number: 11746094
    Abstract: The invention relates to small photosensitizers, their process of preparation and uses of the compounds in optical imaging and photodynamic therapy. The invention provides a compound of formula (I), a derivative or a salt thereof Wherein R1 is selected from the group consisting of amines, anilines, phenols, thiophenols, selenols and aryl groups; R2 and R3 independently are H or halogen; R4 is selected from the group consisting of H, nitro and cyano: and R5 and R6 independently are either absent or oxygen or methyl.
    Type: Grant
    Filed: March 17, 2020
    Date of Patent: September 5, 2023
    Assignee: The University Court of the University of Edinburgh
    Inventors: Marc Vendrell, Antonio Fernandez, Sam Benson, Nicole D. Barth, Fabio De Moliner